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ABSTRACT 
 The process of germ cell cyst breakdown and primordial follicle formation that begins 
during embryonic development in mammalian ovaries is vital for future reproductive success 
because it establishes the total pool of viable egg cells the female will have for the rest of her 
life. Germ cells arrive at the gonad in the mouse at approximately 10.5 days post coitum and 
begin to form germline cysts through incomplete mitosis. At 13.5 days post coitum, the germ 
cells enter meiosis and begin to progress through prophase I of meiosis I. Germ cells progress 
through a series of sub-phases of prophase I starting at pre-meiotic interphase and then moving 
through leptotene, zygotene, pachytene, and eventually arresting at the diplotene stage. The germ 
cells enter diplotene arrest beginning at 17.5 days post coitum, which corresponds with the start 
of cyst breakdown. As more germ cells arrive at diplotene and cysts begin to break down to form 
primordial follicles, some oocytes experience programmed cell death. The protein MSY2 is 
believed to be upregulated at the diplotene stage and therefore could be used as a marker for 
diplotene. Through analysis of the MSY2 protein from 15.5 days post coitum through postnatal 
day 5 using immunohistochemistry, we were able to see an increase in expression over time. The 
increase of expression was expected as our current model suggests that more cells should be 
arriving at diplotene as development progresses. Synaptonemal complex protein 3 (SYCP3) has 
been shown to be expressed during the pachytene stage of meiotic prophase I and therefore can 
be used as a marker for this developmental stage. Analysis of SYCP3 starting at 13.5 days post 
coitum through postnatal day 5 using immunohistochemistry showed the greatest percentage of 
oocytes in the pachytene stage at postnatal day 1. Exogenous hormone exposure on developing 
ovaries can disrupt cyst breakdown and follicle formation, but the process by which the hormone 
exposure disrupts the cyst breakdown is not well understood. It is also unclear how hormones 
affect progression through prophase I of meiosis. Recreating environments that mimic exogenous 
hormone exposure that a female might experience can lead to a better understanding of how 
early such exposure can lead to further issues with fertility. To examine the effect or effects of 
hormones on meiosis, ovaries were dissected at 17.5 days post coitum and grown in culture for 
four days, reaching postnatal day 3, in the presence of 10
-6
 M estradiol, 10
-6 
M progesterone, 
both 10
-6
 M estradiol and 10
-6
 M progesterone, or neither hormone. Ovaries were fixed and 
double labeled with MSY2 and oocyte marker TRA98 or SYCP3 and oocyte marker VASA. We 
found a decrease in MSY2 expression and an increase in the number of oocytes in the pachytene 
stage following hormone treatment, suggesting that estradiol and progesterone can block 
progression to the diplotene stage of meiosis. This work will contribute to our understanding of 
the effects of hormones on oocyte development by determining if there are any disruptions in 
development following the exposure. Information regarding the timing of hormone exposure 
with regards to the extent of developmental disruptions will allow for a clearer timeline of when 
an individual could experience fertility issues through such exposure.  
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Chapter 1: INTRODUCTION 
Significance 
 Infertility in humans is defined as the inability to reproduce by natural means. The ability 
of a female to reproduce is essential to the survival of a species. It is vital to understand the 
processes that underlie a female’s fertility in order to better the chances of survival for the 
species. Not only is it important to comprehend the normal process of reproduction, but it is 
crucial to understand why many individuals, both male and female, experience infertility. 
Creating this knowledge base can then assure a more fruitful future for that individual.  In a 
recent poll of the United States, it was found that 7.5 million individual females, between the 
ages of 15 – 44, had impaired fecundity (Chandra et al., 2013). Impaired fecundity can mean that 
the female may not be able to conceive a child or that she may be able to conceive a child, but 
not be able to carry the child full term. There are many potential causes for why a female might 
experience this issue including: DNA damage in the oocyte, predisposed genetic issues, or 
external environmental factors. Along with these possible fertility complications, females are 
also born with a finite number of germ cells that decreases as the female matures and eventually 
reaches the period of reproductive senescence (Kim and Tilly, 2004). The number of females 
experiencing infertility issues is staggering and the available treatments, such as medication, 
surgery, and in vitro fertilization, come with their own difficulties including a high price tag and 
no guarantee of improving the fertility of the individual. It is essential that this issue is further 
investigated and understood in order to create better treatments that may not only be more cost 
effective, but also much less invasive. 
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Germ Cell Development in Mammalian Ovaries 
 For a female to reproduce, proper development of germ cells within the ovary must 
occur. This process is tightly regulated to create viable eggs that will have the opportunity to 
become fertilized. Starting around 6.5 days post coitum (dpc), or days after mating in mice, a 
subset of cells are committed to become germ cells (Saffman and Lasko, 1999). Around 10.5 
dpc, the germ cells arrive at the gonad and begin to undergo mitosis and divide rapidly to 
increase germ cell numbers (Figure 1) (Peters, 1970). During these divisions, the germ cells are 
found in large clusters that synchronously divide and are known as germline cysts (Pepling and 
Spradling, 1998). Each germline cyst arises from a single germ cell (Pepling et al., 1999). As 
these cells divide, they do not complete cytokinesis and therefore remain connected by 
intercellular bridges that may allow for the exchange of important developmental signaling 
molecules (Pepling and Spradling, 1998). This division takes place until around 13.5 dpc when 
the cells then begin to enter the first of two meiotic divisions. 
 Starting at 13.5 dpc, the germ cells enter prophase I of meiosis I. The cells complete pre-
meiotic interphase and progress through leptotene, zygotene, pachytene, and diplotene stages 
(Pepling, 2006). This process occurs in a wave starting from the anterior end of the ovary to the 
posterior end (Borum, 1961; Menke et al., 2003). Once the diplotene stage is reached, the germ 
cells arrest and remain arrested until further signals are produced, typically after puberty, that 
allow the cell to be released and developed into a mature egg cell that is ready to be fertilized. 
Oocytes begin to arrest at diplotene around 17.5 dpc and the process continues as more germ 
cells progress through meiosis. At about PND5 almost all oocytes are arrested at the diplotene 
stage. 
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Figure 1 
Timeline of mouse germ cell development. Germ cells are shown in green and somatic cells 
are shown in red. At 10.5 dpc, germ cells migrate to the gonad and begin rapidly dividing 
through mitosis, forming cysts. Beginning at 13.5 dpc, mitosis stops and germ cells begin to 
enter meiotic prophase I. Oocytes continue through meiosis progressing through leptotene, 
zygotene, pachytene, and diplotene stages. The oocytes arrive and begin to arrest at the 
diplotene stage at 17.5 dpc. At this time, germline cysts begin to breakdown and germ cells 
that are not lost due to apoptosis are surrounded by somatic cells forming primordial follicles. 
(Adapted from Pepling, 2006) 
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Follicle Formation and Cyst Breakdown 
 For primordial follicles to form within the ovary, germline cyst breakdown must occur. A 
primordial follicle is a single germ cell surrounded by a single layer of somatic cells, called 
granulosa cells. The somatic cells move between germ cells within cysts and are believed to play 
a role in separating the cells (Pepling and Spradling, 2001). Along with the somatic cells moving 
between germ cells and breaking apart the germline cysts, apoptosis of germ cells also plays a 
crucial role in the cyst breakdown and follicle formation process (Coucouvanis et al., 1993; 
Pepling and Spradling, 2001). The loss of germ cells through programmed cell death correlates 
with primordial follicle formation (Greenfeld et al., 2007; Pepling and Spradling, 2001). The 
surviving germ cells that progress into primordial follicles then establish the total pool of germ 
cells the female will have for their whole reproductive lifespan. 
 
Effects of Hormones on Meiotic Progression and Cyst Breakdown 
The process of germ cells dividing through mitosis and forming germline cysts prior to 
entering meiosis has been extensively studied and well documented in the field. From that 
knowledge base, further investigation into meiotic progression and cyst breakdown was 
conducted and it was hypothesized that germ cells remain in cysts due to hormone exposure from 
the mother and the cysts begin to breakdown at birth once the hormone levels significantly drop. 
Thus, contexts where sustained elevated hormones prevail may lead to serious defects in ovarian 
development. 
Studies to investigate the effects of estrogens on cyst breakdown and follicle formation 
have been done both in vivo and in vitro using varying concentrations of estradiol, one of the 
mammalian estrogens (Figure 2) (Chen et al., 2007). Ovaries from neonatal pups injected with 
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estradiol and ovaries grown in an organ culture system with the addition of estradiol both 
showed a significant disruption in cyst breakdown and significantly fewer follicles that were also 
developmentally delayed (Chen et al., 2007). This agrees with previous studies that investigated 
the role of estrogens through the exposure of genistein, a soybean phytoestrogen, which has 
estrogenic activity that disrupted cyst breakdown and follicle formation (Jefferson et al., 2006). 
Along with the disruption of cyst breakdown, estrogen has also been shown to induce multiple 
oocyte follicles (MOFs) in adult ovaries which are mature follicles containing more than one 
germ cell, thought to be the result of cysts that never broke down (Iguchi et al., 2001). The 
genistein exposure also produced the same result, confirming the estrogen effect of promoting 
the production of MOFs (Jefferson et al., 2002). These MOFs are less viable than single oocyte 
follicles due to improper breakdown of the cyst. The method by which estrogen can cause these 
effects has been further investigated, and it has been shown that there are multiple pathways by 
which estrogen can signal to the oocyte through the use of multiple estrogen receptors (Chen et 
al., 2009). 
Progesterone has also been shown to have a negative effect on ovarian development 
through the disruption of cyst breakdown and follicle formation (Chen et al., 2007). Ovaries 
grown in an organ culture system with the addition of progesterone or estradiol + progesterone 
also had a disruption of cyst breakdown and a delay in follicle development (Chen et al., 2007). 
Recently, the receptor by which progesterone acts, progesterone receptor membrane component 
1 (PGRMC1), to disrupt cyst breakdown and follicle formation was discovered (Guo et al., 
2016). It was also shown that progesterone acts via PGRMC1 to suppress oocyte progression 
through meiotic prophase I. 
6 
 
Further investigation showed that there is actually a decrease in maternal progesterone 
levels prior to birth, which initiates cyst breakdown at an earlier time point, but the maternal 
estrogen levels remain high, which maintains some cysts (Dutta et al., 2014). It was also shown 
that the fetal ovary has its own source of hormones that assists in the regulation of cyst 
breakdown and follicle formation (Dutta et al., 2014). In either case, it is clear that the hormone 
exposure on the developing germ cells has an effect and is causing the oocytes to remain in cysts. 
 
 
 
 
 
 
 
 
Figure 2 
Model for cyst breakdown and estrogen signaling. Timeline shows normal cyst breakdown on 
top and cyst breakdown being affected by estrogen treatment on the bottom. After birth, 
estrogen levels fall and cyst breakdown can occur. When additional estrogen is introduced, 
cyst breakdown is disrupted and follicle formation is delayed. (Adapted from Jefferson et al., 
2006)  
 
7 
 
MSY2 Expression in the Ovary 
 The Y-Box protein MSY2 is a member of the Y box multigene family of nucleic acid 
binding proteins (Gu et al., 1998). MSY2 is specifically expressed in both male and female germ 
cells and has also been shown to be maternally inherited (Gu et al., 1998). Expression of MSY2 
is localized to the cytoplasm of germ cells and has a temporal expression pattern which suggests 
a function of storage and translation of mRNAs (Gu et al., 1998). Also MSY2 is very abundant 
within the oocyte and makes up about 2% of total oocyte protein (Yu et al., 2001). The protein is 
believed to be involved in regulating global stability of mRNA and when the gene is deleted, 
females become sterile (Yang et al., 2005). It has been shown in several studies that when there 
is a loss of MSY2 expression within an organism, the individual becomes infertile and different 
phenotypic changes are observed, such as decreased folliculogenesis and a reduction in oocyte 
number (Medvedev et al., 2011). 
 Within the field of reproduction, MSY2 has been widely used as a marker for diplotene 
arrest of oocytes progressing through meiotic prophase I (Paredes et al., 2005). Therefore, 
characterizing MSY2 using immunohistochemistry could provide insight into the regulation of 
early oocyte development. Also, questions such as which pathways regulate meiotic prophase I 
progression and how environmental factors might disrupt this process can then be addressed. 
 
SYCP3 Expression in the Ovary 
 Synaptonemal complexes (SCs) are structures formed between homologous 
chromosomes during the pachytene stage of meiotic prophase and are involved with 
chromosome pairing and recombination (Meuwissen et al., 1992). There have been three 
isoforms of SC proteins (SYCPs), SYCP1, SYCP2, and SYCP3 (also known as SCP1, SCP2, 
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and SCP3) that have been identified in mammals (Lammers et al., 1994; Meuwissen et al., 1992; 
Offenberg et al., 1998). These SCs contain two proteinaceous axes, lateral elements (LEs) found 
along each homologue and transverse filaments (TFs) that connect LEs (Lammers et al., 1994; 
Meuwissen et al., 1997). Mutant forms of SC components can lead to chromosome instabilities 
which, in turn, can produce a number of different problems, including cancer. A mutation in 
SYCP3 specifically was shown to lead to reproductive problems in people (Lopez-Carrasco et 
al., 2013).  
 SYCP3, in particular, has been observed to be located in lateral elements of SCs 
specifically (Ollinger et al., 2005). The expression of SYCP3 mRNA has been detected in 
primordial germ cells (PCGs), pre-meiotic germ cells and meiotic prophase I oocytes (Zheng et 
al., 2009). The expression pattern of SYCP3 protein is distinct within meiotic prophase I oocytes 
during the pachytene stage and is therefore used as a marker for pachytene within the field of 
reproduction (Grive et al., 2016). However, until now, the majority of research conducted 
investigating SYCP3 has used chromosome spreads to visualize individual cells. Chromosome 
spreads involve the destruction of an ovary and the compression of cells in order to isolate single 
germ cells. The characterization of SYCP3 in whole mount ovaries through 
immunohistochemistry can provide a larger scale representation of the protein throughout the 
entire ovary and can then be used as a tool by creating an expression profile in a normal ovary 
that can be used for baseline comparisons. Therefore, further investigation of a variety of factors 
that may influence germ cell development either negatively, such as exogenous hormones that 
disrupt cyst breakdown, or positively, such as the addition of KIT ligand to promote cyst 
breakdown, can be performed. 
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Specific Aims 
 Current methods used to stage and analyze female germ cell development are tedious, 
time consuming, and often do not allow researchers to gain an understanding of the ovary as a 
whole. Present methods include hematoxylin and eosin (H&E) staining that requires the 
mounting, sectioning (through slicing), and staining of the ovary and chromosome spreads, 
which we described above. Both of these methods deconstruct the ovary and require extensive 
protocols in order to complete. Given the importance of female infertility research, it is vital to 
help improve research techniques that will provide more information at a more time effective 
pace. The goals of my research are to use MSY2 expression levels and SYCP3 expression 
pattern in whole mount immunohistochemistry as tools to analyze meiotic progression and to 
determine the effects of estrogen and progesterone on meiotic progression analyzed by MSY2 
protein levels and SYCP3 expression. 
The specific aims for this thesis are:  
1. Use MSY2 expression levels and SYCP3 expression pattern in whole mount 
immunohistochemistry as tools to analyze meiotic progression. 
2. Determine the effects of estrogen and progesterone on meiotic progression analyzed by 
MSY2 protein levels and SYCP3 expression. 
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Chapter 2: MATERIALS AND METHODS 
Animal Model 
 The mouse model used in this research is the inbreed strain C57BL/6J. Males and 
females are caged separately with two to five individual animals per cage until ready to breed. 
The animals are kept on a 14 hour light/10 hour dark cycle. The cages are changed once a week 
to provide fresh food, water, and bedding. All work done has been approved by the Institutional 
Animal Care and Use Committee (IACUC). 
 
Checking Vaginal Plugs and Staging Mouse Development 
 After male and female mice are placed together in a cage, females are checked for 
vaginal plugs for the following four days. To check for a vaginal plug, females are raised from 
the tail end and, using a pair of forceps, the vagina is slightly opened and inspected. If a female 
has a small white bump consisting of coagulated secretions from the coagulating and vesicular 
glands of the male inside of the vaginal opening, she is considered plugged (pregnant), separated 
into her own cage, and is expected to give birth 19 days later. If on day five the female is still not 
plugged, she is considered a no plug female and separated into her own cage and observed for 
the next 19 days to make sure she is not pregnant.  
 Animals are staged by their plug date. Therefore, when a female is found to be plugged, 
she is considered to be 0.5 dpc. A total of 19 days are counted out following the plug date and 
that is considered the expected delivery date (19.5 dpc or PND1). Using this timeline, the age of 
the pups can be determined. 
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Ovary Harvesting 
Ovaries were harvested from wildtype C57BL/6J pups at multiple time points during 
development. Harvested ovaries ranged in development from 13.5 dpc to PND5. In order to 
harvest ovaries from embryos (13.5 dpc to 18.5 dpc), mothers were sacrificed via CO2 
asphyxiation and embryos were removed from the mother. Postnatal pups (PND1 to PND5) were 
collected from animal cages housed with mothers. All pups were sacrificed via decapitation as 
stated in the lab’s animal protocol. Once pups were sacrificed, ovaries were harvested from 
female pups, excess tissue surrounding the ovaries was removed, and the ovaries were placed 
into the proper solution depending on the protocol. When sacrificing mothers for the collection 
of embryos, a maximum of two adult females were sacrificed at a time in order to avoid the 
degradation of essential proteins before ovaries could be collected. When sacrificing postnatal 
pups, a maximum of four pups were sacrificed at a time, also to avoid the degradation of 
essential proteins. 
 
Whole Mount Immunohistochemistry 
 Once ovaries were harvested, they were placed into 5.3% formaldehyde to fix the tissue 
(16% EM grade formaldehyde diluted in 1X PBS). Ovaries were fixed overnight at 4°C on a 
nutator. After fixation, ovaries went through a series of washes at room temperature in 0.1% 
Triton X-100 in 1X PBS (PT) and PT + 5% bovine serum albumin (BSA). Following the washes, 
the ovaries were incubated overnight with primary antibodies at varying concentrations in PT + 
5% BSA at 4°C. Primary antibodies are listed in Table 1. 
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Table 1. Primary Antibodies Used for Immunohistochemistry 
Primary 
Antibody 
Company Catalog # Species Made In Dilution 
MSY2 (C-15) Santa Cruz 
Biotechnology 
sc-21316 
Lot #: C0615 
Goat 1:100 
SYCP3 (D-1) Santa Cruz 
Biotechnology 
sc-74569 
Lot #: J1314 
Mouse 1:200 
STAT3 (C-20) Santa Cruz 
Biotechnology 
sc-482 
Lot #: I0613 
Rabbit 1:500 
TRA98 B-Bridge 73-003 
Lot #: 141113A 
Rat 1:500 
VASA Abcam ab-13840 
Lot #: 
GR172688-1 
Rabbit 1:250 
 
After overnight incubation in primary antibody, ovaries went through another series of washes 
including: PT + 1% BSA for 30 minutes, RNase A (10 µl of 10 mg/ml RNase A in 1 ml PT + 1% 
BSA) for 30 minutes, propidium iodide (10 µl of 0.5 mg/ml in 1 ml PT + 1% BSA) or TOTO3 
(Molecular Probes; 1:2000 dilution in PT + 1% BSA) for 20 minutes in the dark (samples 
remained in dark environment after this wash), and one more wash in PT + 1% BSA for 30 
minutes. RNase A was used to degrade any residual single stranded RNA present in the sample 
in order to eliminate potential background staining in the cytoplasm. Propidium iodide or 
TOTO3 was used to label the nuclei of all cells present in the sample. Ovaries were then 
incubated with pre-absorbed secondary antibodies overnight at 4°C in order to eliminate any 
nonspecific staining. Negative controls using only the secondary antibody were previously tested 
in the lab for all antibodies used. Secondary antibodies were pre-absorbed using a small amount 
of embryo powder overnight at 4°C. Secondary antibodies used are listed in Table 2. The 
embryo powder was prepared from 14.5 dpc embryos by taking whole embryos, dehydrating 
them, and grinding them down to a powder. 
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Table 2. Secondary Antibodies Used for Immunohistochemistry 
Secondary Antibody Company Catalog # Species Made In Dilution 
Alexa Fluor 488 
Donkey Anti-Goat 
Molecular 
Probes/Invitrogen 
A11055 Donkey 1:200 
Alexa Fluor 488 
Donkey Anti-Mouse 
Molecular 
Probes/Invitrogen 
A21202 Donkey 1:200 
Alexa Fluor 488 
Donkey Anti-Rabbit 
Molecular 
Probes/Invitrogen 
A21206 Donkey 1:200 
Alexa Fluor 488 
Donkey Anti-Rat 
Molecular 
Probes/Invitrogen 
A21208 Donkey 1:200 
Alexa Fluor 488 
Goat Anti-Mouse 
Molecular 
Probes/Invitrogen 
A11029 Goat 1:200 
Alexa Fluor 488 
Goat Anti-Rabbit 
Molecular 
Probes/Invitrogen 
A11008 Goat 1:200 
Alexa Fluor 488 
Rabbit Anti-Goat 
Molecular 
Probes/Invitrogen 
A11078 Rabbit 1:200 
Alexa Fluor 568 
Donkey Anti-Goat 
Molecular 
Probes/Invitrogen 
A11057 Donkey 1:200 
Alexa Fluor 568 
Donkey Anti-Rabbit 
Molecular 
Probes/Invitrogen 
A10042 Donkey 1:200 
Alexa Fluor 568 
Goat Anti-Mouse 
Molecular 
Probes/Invitrogen 
A11004 Goat 1:200 
 
Secondary antibodies were used at a 1:200 dilution in PT + 5% BSA. Following overnight 
incubation, ovaries were washed in PT + 1% BSA at room temperature three times for 30 
minutes each. Ovaries were then quickly rinsed in PBS, placed in vectashield to prevent fading, 
and mounted onto large cover slips. 
 
Fluorescent Microscopy 
 Ovaries were fixed and stained through immunohistochemistry as described in the 
previous section. After ovaries were stained, they were imaged through fluorescent microscopy 
on the confocal microscope (Zeiss LSM 710 System with an Axio Observer). In order to create 
an MSY2 expression pattern profile, ovaries were viewed under 63X magnification and the 
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“field of most oocytes” was located. A single image for each ovary was captured and scored to 
create the profile. For each ovary, an expression pattern profile was also created for SYCP3 by 
viewing the ovaries under 63X magnification and taking two cores of four images each, with the 
images separated by 20 microns. In order to score ovaries treated in organ culture, z-stacks were 
created under 63X magnification as well. Stacks consisted of 11 images, each one micron apart, 
surrounding each center image (Figure 3). 
  
 
 
Analysis of Meiotic Progression 
 Ovaries at multiple stages of development were imaged on the confocal microscope and 
then manually counted. A series of images were taken for each ovary (as explained in previous 
section) in order to gain a complete representation of the protein expression in the ovary (Figure 
3). The images were then processed by examining all of the oocytes present in each section and 
Figure 3 
Schematic showing method in which ovaries were analyzed through confocal microscopy. 
Each ovary was analyzed by taking 2 cores of 4 images each 20 µm apart. Around each 
image, a stack of 11 images (5 above and 5 below) each 1 µm apart was taken. 
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analyzing each ovary in several categories. For distinguishing oocytes reaching and arresting at 
the diplotene stage, the following categories were scored: oocyte number, number of oocytes 
strongly expressing MSY2 protein, oocytes weakly expressing MSY2 protein, and oocytes not 
expressing MSY2 protein. To distinguish oocytes reaching the pachytene stage, the expression 
pattern of SYCP3 was analyzed over a series of developmental stages and the number of oocytes 
displaying the pattern of expression congruent with pachytene were counted. 
 
In vitro Ovary Organ Culture 
 Ovaries for in vitro ovarian organ culture were harvested from 17.5 dpc embryos. The 
ovaries were harvested in petri dishes filled with Hank’s Balanced Salt Solution. Once the 
ovaries were dissected from the pups and all excess tissue was removed, the ovaries were 
transferred onto a filter located in a six-well tissue culture plate kept on ice. Directly before 
adding the ovaries to the filter, 1.0 ml of cold Hank’s Balanced Salt Solution was added to the 
well. A total of two ovaries were added to each filter in each well, leaving a maximum of 12 
ovaries possible per plate. After all ovaries were harvested and transferred onto their filter, the 
filters were then transferred to a new sterile six-well tissue culture plate under a sterile hood. 
 After transferring filters to a new sterile plate, 1.2 ml of warm stock culture media was 
added to each well under a sterile hood. The media was warmed in a water bath set to 37°C. The 
stock culture media was prepared using the following solutions: L-ascorbic acid (0.05 mg/ml in 
DMEM), 10% Albumax stock, 7.5% BSA, penicillin/streptomycin, and DMEM complete media 
(Invitrogen). The tissue culture plate was then placed in a sterile incubator pre-set at 37°C and 
5% CO2 for one hour to acclimate the ovaries. Following the hour acclimation period, the media 
was removed from each well and 1.2 ml of fresh media is added. At this point, the stock culture 
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media was replaced with treatment media. Treatments included: estradiol (β-estradiol ≥98%; 
Sigma E8875) (10
-6
 M in DMSO), progesterone (progesterone ≥99%; Sigma P0130) (10
-6
 M in 
DMSO), and estradiol & progesterone (10
-6
 M in DMSO for both). Vehicle controls using 
DMSO were also included in the treatments (0.001% DMSO and 0.002% DMSO). Once the 
treatment media was added, tissue culture plates were placed back into the incubator for 22 to 26 
hours. Treatment was replaced in the same manner for the following three days and then 
terminated on the fifth day.  
 In order to terminate the organ culture, media was removed from each well and replaced 
and washed with warm Hank’s Balanced Salt Solution. Once rinsed, ovaries were removed from 
the filters and placed into fixative (5.3% formaldehyde in 1X PBS) overnight at 4°C. Ovaries 
were then stained with MSY2, SYCP3, TRA98, VASA, TOTO3, or PI (or combination of 
multiple antibodies) as described earlier in the immunohistochemistry section. 
 
Analysis of Oocyte Development and Cyst Breakdown 
 After ovary samples were collected, treated in organ culture, stained through 
immunohistochemistry, and imaged through confocal microscopy, as described in previous 
sections, the ovaries were scored for the following categories: oocyte number, cyst breakdown, 
follicle development, and meiotic progression. A total of eight images per ovary and a total of 
eight ovaries per developmental stage were scored and averaged together. Oocyte number was 
collected by counting the total number of visible oocytes that were present within the field of the 
image. More than 50% of the nucleus had to be within the field of view in order to be scored. 
Cyst breakdown was analyzed by scoring the number of single oocytes versus the number of 
oocytes still in cysts. The numbers were converted into percentages and averaged. In order to 
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distinguish the different stages of follicle development, follicles were observed and scored based 
on the developmental status. Follicles were either scored as primordial, germ cell surrounded by 
flattened granulosa cells, primary, germ cell surrounded by a layer of cuboidal granulosa cells, or 
secondary, germ cell surround by multiple layers of cuboidal granulosa cells.  Finally, the 
oocytes were scored for meiotic progression through the analysis of either MSY2 (diplotene) or 
SYCP3 (pachytene). Expression of either MSY2 or SYCP3 was analyzed and counted to 
determine the meiotic staging of each oocyte. 
 
Statistical Analysis 
 Unpaired, two-tailed t-tests were performed to analyze the effects of hormone treatments 
through organ culture on oocyte number, cyst breakdown, follicle development, and meiotic 
progression. T-tests were performed through Microsoft Excel 2013 with a p<0.05 considered as 
significant.  
 One-way ANOVA’s were performed to analyze the difference in expression of meiotic 
markers MSY2 and SYCP3 across the developmental timeline, variance between pairs of ovaries 
of littermates, and the difference between in vivo and in vitro ovarian samples. GraphPad PRISM 
statistical software was used to perform ANOVA’s with Bonferroni’s (<5 groups) and Newman-
Keuls (≥5 groups) Multiple Comparison posttests indicating p<0.05 as significant. 
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Chapter 3: RESULTS 
MSY2 Expression Correlates with Diplotene Arrest 
 In order to follow and stage meiotic progression, specific meiotic markers were chosen to 
create expression profiles. First, MSY2 expression was used to identify oocytes at the diplotene 
stage of meiotic prophase I. MSY2 expression was analyzed within the female germ cells over 
the developmental period starting from 15.5 dpc through PND 5. Each oocyte was counted and 
marked as either strongly expressing or weakly expressing MSY2 (Figure 4). Strong expression 
of MSY2 within an oocyte indicates that the cell has reached and arrested at the diplotene stage 
of meiotic prophase I. Asymmetric expression of MSY2 was observed within the same ovarian 
cysts in multiple confocal sections. 
 
 
 
 
 
 
 
Figure 4 
Asymmetric expression of MSY2 protein in wildtype ovaries. Image shown is a confocal 
microscope section from a PND1 wildtype ovary. (A) MSY2 expression labeled in green. (B) 
Nuclei of all cells labeled with propidium iodide in red. (C) Overlay of both MSY2 (green) 
and propidium iodide (red) channels. Asterisk indicates an oocyte strongly expressing MSY2. 
Square indicates an oocyte with weak MSY2 expression. The arrow and arrowhead are 
showing an example of asymmetric expression of MSY2 within the same cyst. The arrow 
indicates an oocyte with weak MSY2 expression within the cyst and the arrowhead indicates 
an oocyte with strong MSY2 expression within that same cyst. Scale bar = 20 µm. 
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Once all sections were counted and analyzed for MSY2 expression, an expression profile was 
created for the developmental stages of 15.5 dpc through PND5 (Figure 5). Strong expression of 
MSY2 was seen to be at ~40% as early as 15.5 dpc and the percent of germ cells strongly 
expressing MSY2 increased over the developmental time points. At PND5, almost all (~94%) 
oocytes were strongly expressing MSY2. The increase in oocytes strongly expressing MSY2 
correlates with expected increase in oocytes arriving at and arresting at the diplotene stage of 
meiotic prophase I. 
 
 
 
 
 
 
Figure 5 
MSY2 expression correlates with the progression of oocyte development to the diplotene 
stage of meiotic prophase I. Percent of oocytes with strong MSY2 labeling in ovaries (+/-
SEM) from 15.5 dpc through PND5. Different letters indicate a significant difference between 
groups (P<0.05; n = 8 ovaries per developmental stage) as determined by a one-way ANOVA 
followed by Newman-Keuls multiple comparisons test. 
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SYCP3 Expression Correlates with the Pachytene Stage of Meiotic Prophase I 
 A second expression profile, using SYCP3, was created to follow and stage meiotic 
progression. SYCP3 expression was analyzed within the female germ cells over the 
developmental period starting from 13.5 dpc through PND 5. Each oocyte was analyzed through 
the SYCP3 expression pattern to be either in the pachytene stage of meiotic prophase I or not 
(Figure 6). Expression of SYCP3 in the pachytene stage is found as condensed “strings” 
between homologous chromosomes. 
  
 
 
 
 
 After the number of pachytene staged oocytes was counted, a profile was created 
reporting the percent of oocytes observed in pachytene (Figure 7). Oocytes in the pachytene 
stage were not seen until 16.5 dpc. After 16.5 dpc, an increase in the number of pachytene 
labeled oocytes increased until PND1 where a peak of ~55% was seen. Starting at PND2, the 
number of oocytes at the pachytene stage significantly decreased and no cells were observed to 
be in pachytene after PND3. 
Figure 6 
Confocal microscope section showing expression pattern of SYCP3 in PND1 wildtype ovary. 
(A) SYCP3 expression labeled in green. (B) Nuclei of all cells labeled with propidium iodide 
in red. (C) Overlay of both SYCP3 (green) and propidium iodide (red) channels. Circled 
oocytes show expression pattern of SYCP3 in pre/post pachytene stage. Arrowhead is 
showing expression pattern of SYCP3 in an oocyte in the pachytene stage. Scale bar = 20 µm. 
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Examining the Effects of Steroid Hormones on Meiotic Progression by Analysis of a 
Diplotene Arrest Marker 
 The effects of exogenous hormone exposure on cyst breakdown, follicle formation, and 
meiotic progression of developing ovaries was tested through treatment of estradiol and/or 
progesterone. 17.5 dpc ovaries were harvested and grown in vitro using an organ culture system. 
Ovaries were grown for five days (four 24 hour periods) in various treatment groups (0.001% 
DMSO vehicle, 0.002% DMSO, 10
-6
 M estradiol, 10
-6
 M progesterone, and 10
-6
 M estradiol + 
progesterone) until they reached PND3 (Figure 8A). Once at PND3, ovaries were fixed and 
Figure 7 
Percent of oocytes in the pachytene stage of development in ovaries from 13.5 dpc through 
PND5. Staging of oocytes determined through SYCP3 expression pattern (+/-SEM). Different 
letters indicate a significant difference between groups (P<0.05; n = 8 ovaries per 
developmental stage) as determined by a one-way ANOVA followed by Newman-Keuls 
multiple comparisons test. 
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stained with MSY2 and TRA98 (germ cell marker) through immunohistochemistry and then 
analyzed through confocal microscopy (Figure 8B). Analysis was done by taking two cores of 
four images as explained in the previous section (Figure 3). 
 
 
 
 
 
 
 Once imaged through confocal microscopy, ovaries were analyzed for oocyte number, 
cyst breakdown, follicle development, and meiotic progression. Estradiol and progesterone 
appeared to have no effect on oocyte number or follicle development (Figure 9A and 9C). 
However, the treatments of estradiol alone and estradiol with progesterone did significantly 
disrupt cyst breakdown and decrease the percent of single oocytes in each section (Figure 9B). 
Figure 8 
Organ culture with hormone treatment analyzed by MSY2 expression experimental set up. 
(A) Timeline of organ culture experiment procedure. (B) Representative confocal section 
labeled with MSY2 (red), TRA98, oocyte marker (green), and TOTO3, nuclear marker (blue). 
Oocytes marked as strong (S), weak (W), or no (N) expression. Scale bar = 20 µm. 
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Figure 9 
Effects of estradiol and progesterone on oocyte development in organ culture examining 
diplotene arrest from first series of organ culture experiments. (A) Number of oocytes per 
confocal section after 5 days in culture with varying treatments (+/-SEM). (B) Percent single 
oocytes after 5 days in culture with varying treatments (+/-SEM). Asterisk indicates 
significant difference from control (P<0.05) as determined by a two-tailed T-test. (C) Percent 
of follicles at different stages of development after 5 days in culture with varying treatments. 
n = 8 ovaries per treatment group. Three replicates were performed. 
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 Following the in vitro organ culture experiment, oocytes were marked as either 
expressing MSY2 strongly, weakly, or not at all in order to analyze the effects of hormone 
exposure on meiotic progression. Progesterone significantly lowered the percent of oocytes 
strongly expressing MSY2 and significantly increased the percent of oocytes with no MSY2 
expression (Figure 10). Estradiol as well as both hormones together did not have a significant 
impact on MSY2 expression. 
 
 
 
 
 
 
 
Figure 10 
Progesterone but not estradiol reduces MSY2 expression. Graph showing the percentage of 
oocytes expressing MSY2 strongly, weakly or not at all (+/-SEM). Asterisk indicates 
significant difference from control (P<0.05; n = 8 ovaries per treatment group) as determined 
by a two-tailed T-test. 
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Examining the Effects of Steroid Hormones on Meiotic Progression by Analysis of 
Pachytene Oocytes 
 Another set of in vitro organ culture experiments were conducted using the same protocol 
as previously described in order to analyze the effects of exogenous hormone exposure on 
developing ovaries using a marker for the pachytene stage. Again, 17.5 dpc ovaries were 
harvested and grown in vitro using an organ culture system. Ovaries were grown for five days 
(four 24 hour periods) in various treatment groups (0.001% DMSO vehicle, 0.002% DMSO, 10
-6
 
M estradiol, 10
-6
 M progesterone, and 10
-6
 M estradiol and progesterone) until they reached 
PND3 (Figure 11A). Once at PND3, ovaries were fixed and stained with SYCP3 and VASA 
(germ cell marker) through immunohistochemistry and then analyzed through confocal 
microscopy (Figure 11B).  Ovaries were analyzed with the same protocol (Figure 3). 
 
 
 
 
Figure 11 
Organ culture with hormone treatment analyzed by SYCP3 expression experimental set up. 
(A) Timeline of organ culture experiment procedure. (B) Representative confocal section 
labeled with VASA, oocyte marker (red), SYCP3 (green), and TOTO3, nuclear marker (blue) 
showing pachytene expression pattern. Scale bar = 20 µm. 
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 Neither estradiol nor progesterone were seen to have an effect on cyst breakdown or 
follicle development in the second series of organ culture experiments, but treatment with both 
estradiol and progesterone did significantly decrease the number of oocytes per section (Figure 
12). When results are compared to in vivo data of the same developmental stage, there appears to 
be a promotion of development in ovaries in vitro. Number of oocytes per section is reduced and 
the percent of single oocytes is increased in vitro when compared to in vivo. 
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Figure 12 
Effects of estradiol and progesterone on oocyte development in organ culture examining germ 
cell progression to the pachytene stage from second series of organ culture experiments. (A) 
Number of oocytes per confocal section after 5 days in culture with varying treatments (+/-
SEM). Asterisk indicates significant difference from control (P<0.05) as determined by a two-
tailed T-test. (B) Percent single oocytes after 5 days in culture with varying treatments (+/-
SEM). (C) Percent of follicles at different stages of development after 5 days in culture with 
varying treatments. n = 8 ovaries per treatment group. Three replicates were performed. 
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 Following the second set of in vitro organ culture experiments, oocytes were labeled with 
SYCP3 and marked as either in pachytene or pre/post pachytene in order to analyze the effects of 
hormone exposure on an earlier stage of meiotic progression. Ovaries treated with estradiol and 
progesterone together had a significant increase in the percent of oocytes in the pachytene stage 
suggesting that progression through meiotic prophase I was delayed (Figure 13). 
 
 
 
 
 
 
 
 
Figure 13 
Estradiol and progesterone have a combined effect on the number of oocytes at pachytene. 
(A) Graph showing the percentage of oocytes in the pachytene stage as determined by SYCP3 
expression pattern (+/-SEM). Asterisk indicates significant difference from control (P<0.05; n 
= 8 ovaries per treatment group) as determined by a two-tailed T-test. 
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No Variance Observed Between Pairs of Ovaries from Litter Mates 
 In order to further justify the results achieved and check for any potential error in 
experimental procedure, variance between pairs of ovaries from PND1 litter mates was analyzed. 
Ovaries are normally pooled together from litter mates when conducting experiments creating 
one set of data. There was no variance observed in the number of oocytes per section, cyst 
breakdown, or follicle development between pairs of ovaries from litter mates. No significant 
difference between pairs was observed in the average number of oocytes per section, the average 
percent of single oocytes, or the average percent of follicles at different developmental stages 
(Figure 14). 
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Figure 14 
No significant variance is observed between pairs of ovaries from individuals within the same 
litter. (A) Number of oocytes per confocal section in separate pairs of ovaries (+/-SEM). (B) 
Percent single oocytes in separate pairs of ovaries (+/-SEM). (C) Percent of follicles at 
different stages of development in separate pairs of ovaries (+/-SEM).  
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Estradiol Confirmed to Disrupt Cyst Breakdown in Later Stage Ovaries 
 Previous studies found estradiol to disrupt cyst breakdown and follicle formation to a 
more substantial degree when conducting organ culture experiments starting with PND1 ovaries 
compared to current experiments starting at 17.5 dpc (Chen et al., 2007). Verification of previous 
results was needed in order to determine if the lesser effect was due to a change in experimental 
design or because of researcher error in performing experiments. Confirmation of results was 
achieved through an organ culture experiment starting with PND1 ovaries and growing them in 
vitro for five days to reach PND5 (Figure 15A). Treatment with estradiol (10
-6
 M in DMSO) 
disrupted cyst breakdown and follicle formation (Figure 15B). 
 
 
 
Figure 15 
Estradiol disrupts cyst breakdown in PND1 ovaries cultured for 5 days. (A) Timeline showing 
treatment process of organ culture experiment. (B) Representative confocal sections of PND5 
vehicle control and estradiol treated ovaries. Ovaries were fixed and stained with MSY2 (red), 
TRA98, oocyte marker (green), and TOTO3, nuclear marker (blue). Scale bars = 20 µm. 
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When analyzed through confocal microscopy, there was a significant decrease in the number of 
oocytes per section and in the percent of single oocytes, but no significant change in follicle 
development (Figure 16A-C). When looking at the effect on meiotic progression through MSY2 
analysis, a significant increase in the number of oocytes not expressing MSY2 at all was 
observed suggesting a potential delay in meiotic progression (Figure 16D). 
 
 
 
 
 
 
 
 
Figure 16 
Estradiol reduces the number of oocytes, disrupts cyst breakdown, and delays meiotic 
progression in PND1 ovaries cultured for 5 days. (A) Number of oocytes per confocal section 
after 5 days in culture with 10
-6
 M estradiol (+/-SEM). (B) Percent single oocytes after 5 days 
in culture with 10
-6
 M estradiol (+/-SEM). (C) Percent of follicles at different developmental 
stages after 5 days in culture with 10
-6
 M estradiol. (D) Percent of oocytes expressing MSY2 
strongly, weakly or not at all after 5 days in culture with 10
-6
 M estradiol (+/-SEM). Asterisk 
indicates significant difference from control (P<0.05; n = 8 ovaries per treatment group) as 
determined by a two-tailed T-test. 
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Organ Culture System has a Negative Effect on Ovarian Health 
 To determine any potential negative effects the organ culture system or the vehicle 
control of DMSO may have had on ovarian health, comparisons of treatment groups and in vivo 
ovaries of the same age were observed. When comparing in vivo control, in vitro control, and in 
vitro DMSO treated ovaries, there is only a significant difference observed between the in vivo 
and in vitro groups. Ovaries grown in an organ culture system have a significantly lower number 
of oocytes per section and higher percent of single oocytes with no change in follicle 
development (Figure 17A-C). Analysis of meiotic progression using MSY2 expression only 
showed a difference in the in vitro control with a significant decrease in the percent of oocytes 
strongly expressing MSY2 and a significant increase in the percent of oocytes not expressing 
MSY2 at all, suggesting the organ culture system significantly delays the progression of oocytes 
through meiosis (Figure 17D). 
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Figure 17 
DMSO does not have a negative effect on ovaries, but organ culture system shows a negative 
effect on ovarian health. (A) Number of oocytes per confocal section both in vivo and after 5 
days in culture with varying treatments (+/-SEM). (B) Percent single oocytes both in vivo and 
after 5 days in culture with varying treatments (+/-SEM). (C) Percent of follicles at different 
developmental stages both in vivo and after 5 days in culture with varying treatments. (D) 
Percent of oocytes expressing MSY2 strongly, weakly or not at all both in vivo and after 5 
days in culture with varying treatments (+/-SEM). Different letters indicate a significant 
difference between groups (P<0.05; n = 8 ovaries per treatment group) as determined by a 
one-way ANOVA followed by Bonferroni’s multiple comparisons test. 
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Chapter 4: DISCUSSION 
 Whole mount immunohistochemistry of ovarian samples was successfully used to 
characterize progression of female germ cells through meiotic prophase I. MSY2, a germ cell 
specific maternal mRNA binding protein, has been shown to be upregulated in oocytes reaching 
and arresting at the diplotene stage (Gu et al., 1998). The use of MSY2 as a marker for diplotene 
arrest was shown through the analysis of YBX2 mRNA (bovine MSY2), which showed an 
increase of mRNA expression in primordial follicles advancing to primary follicles with oocytes 
at the diplotene stage (Yang and Fortune, 2008). It was also originally found and then further 
confirmed that oocytes begin to enter diplotene arrest at 17.5 dpc. In order to link MSY2 
expression with diplotene arrest, MSY2 mRNA levels were analyzed across the developmental 
period from 13.5 dpc through PND5 and it was shown that MSY2 expression does not 
significantly increase until 18.5 dpc which correlates with the timing of diplotene arrest (Dutta 
and Pepling, unpublished). However, in the present experiments, when looking at the MSY2 
characterization through whole mount antibody staining, it was shown that at 15.5 dpc, 41% of 
oocytes were already strongly expressing MSY2. This level of expression is much higher than 
expected given that diplotene arrested oocytes were not even present until 17.5 dpc and MSY2 
mRNA expression did not increase until 18.5 dpc. The expression of MSY2 did increase over 
development correlating with the idea of MSY2 upregulation during diplotene arrest beginning 
with the first significant increase at PND1, and almost all oocytes strongly expressing MSY2 by 
PND5 (94%). This finding suggests that MSY2 is not actually a marker for diplotene arrest, but 
rather its increase in expression over the developmental time period correlates with progression 
of oocytes to the diplotene stage. SYCP3, a protein found in SCs, is involved with chromosome 
pairing and recombination (Meuwissen et al., 1992). This protein has been widely used in the 
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field of reproduction as a marker for meiotic prophase due to its distinct expression pattern 
during the pachytene stage (Grive et al., 2016). However, most work looks at the expression of 
SYCP3 at the cellular level and not in whole mount. Through whole mount antibody staining of 
ovarian samples, I established that the highest percentage of oocytes found in pachytene was 
54% at PND1, which then significantly decreased to 12% at PND2 (Figure 7). This result 
correlates with previous work showing the temporal expression pattern of the pachytene stage 
(Borum, 1961). 
 It should be noted that when imaging ovaries that were stained through 
immunohistochemistry through confocal microscopy, the intensity of the laser did not remain 
constant for each image taken. When moving deeper into the ovary, the intensity of the laser 
needed to be increased in order to visualize the staining of the protein. Laser intensities were 
observed and there was no significant change of laser intensity variance from one developmental 
age to the next. 
 Previous research has shown that estrogens and progesterone have negative effects on the 
development process of female germ cells. Progesterone and estradiol, phytoestrogen genistein, 
as well as synthetic estrogens all disrupt cyst breakdown and follicle formation (Chen et al., 
2007; Jefferson et al., 2006; Karavan and Pepling, 2012) thereby leading to a potential decrease 
in viable egg cells later in life. In some instances, the number of oocytes present was also 
affected, but not as consistently. In the work presented in this thesis, two series of organ cultures 
were completed, each treating ovaries with either estradiol (10
-6
 M), progesterone (10
-6
 M), or 
estradiol and progesterone (10
-6
 M) with little to no effect on cyst breakdown and follicle 
formation. In the first series of organ cultures, no effect was seen on oocyte number or follicle 
development, but there was a small but significant decrease in the percent of single oocytes in 
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both the estradiol alone and estradiol + progesterone groups indicating a disruption of cyst 
breakdown. In the second series, there was no significant effect on the percent of single oocytes 
or follicle development, but there was a significant decrease in the number of oocytes in the 
estradiol + progesterone treatment group. Similar results were expected for each set of 
experiments and the difference in results could be due to a lower average number of oocytes 
present in the second series of organ cultures. Also, even though there was a significant 
disruption of cyst breakdown in some of the treatment groups of the first series, the result was 
much less severe than previously reported. The studies conducted prior to these organ culture 
experiments were initiated on PND1 ovaries, whereas the current studies were started earlier 
with 17.5 dpc ovary samples. This earlier starting point may be out of the window of sensitivity, 
which would lead to little or no visible effects (Dutta et al., 2016). Also, when comparing in vivo 
ovaries similar in developmental age to ovaries treated through organ culture, there does appear 
to be a noticeable decrease in the number of oocytes and increase in the percent of single oocytes 
suggesting either an unfavorable organ culture system environment or a potential acceleration of 
development caused by the organ culture system.  
 Another aspect of the organ culture experiments that was analyzed was the effects of 
estrogen and progesterone on meiotic progression. Again, two series of organ cultures were 
completed with the first series being labeled for MSY2, marker for diplotene, and the second 
series being labeled with SYCP3, marker for pachytene. Previous research has shown that when 
pregnant female mice were exposed to Bisphenol A (BPA), an estrogenic chemical, meiotic 
progression was disrupted by way of a disturbance of the synapsis and recombination of 
chromosome homologs (Susiarjo et al., 2007).  When PND1 ovaries of rats were treated with 
estradiol in an organ culture system, primordial follicle assembly was slightly delayed and 
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transition from primordial to primary follicles was inhibited showing a disruption in 
development (Kezele and Skinner, 2003). However, the major finding was actually that 
progesterone showed a much stronger effect on follicle assembly. Another study showed that 
progesterone acts through the progesterone receptor membrane component 1 (PGRMC1) to 
significantly delay or completely disrupt meiotic progression and therefore disrupt primordial 
follicle assembly (Guo et al., 2016). The results of my organ culture series agreed with these 
findings. In the first series of cultures, strong MSY2 expression (marking cells arrested at 
diplotene) was significantly decreased in only the progesterone treatment and the oocytes not 
expressing MSY2 at all was significantly increased in both the estradiol treatment and the 
progesterone treatment indicating a delay in meiotic progression. In the second series, the 
number of oocytes found in the pachytene stage significantly increased only in the estradiol + 
progesterone treatment group indicating that treatment with both hormones delayed meiotic 
progression. 
 Given some of the unexpected results discovered during the organ culture experiments, it 
was vital to check a number of different potential causes of error including the use of different 
littermates across litters and the impact of comparing developmental processes using explanted 
ovaries into organ cultures and ovaries harvested from whole animals.  
Data collected for organ culture experiments came from pools of ovaries that were 
combined from multiple different litters. Checking for any variance between ovary pairs of 
different individuals from the same litter would eliminate the possibility of skewed data if no 
variance was found. Three pairs of ovaries were compared against each other with no variance 
found justifying the pooling of ovaries from multiple individuals.  
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Moreover, the effects of estradiol treatments at 10
-6
 M on ovaries through an organ 
culture system had been shown to significantly lower the percent of single oocytes and delay the 
progression of follicle development while having no effect on the number of oocytes (Chen et 
al., 2007). Since the effect seen in organ culture here was less severe and the only difference 
from previous work was the age of the ovary when it entered culture (PND1 vs 17.5 dpc), we 
repeated the organ culture to confirm that estradiol would block cyst breakdown if started at 
PND1. Results were only partially replicated with a significant decrease in the percent of single 
oocytes (though much less severe than the published studies from our lab). The number of 
oocytes present was significantly decreased in my experiment and also the follicle development 
was not significantly decreased. We went a step further and looked at the effect of estradiol on 
meiotic progression through the analysis of MSY2 expression and found that there was a 
significant increase in the number of oocytes not expressing MSY2 at all which would indicate a 
delay in meiotic progression. The result combined with the positive result of cyst breakdown 
disruption indicates that there is no issue with the estradiol. However, the significant decrease in 
number of oocytes present within the ovary leads to the assumption that there may be an issue 
with the organ culture system and its ability to maintain the health of the ovaries during culture 
experiments. Previous studies have shown that when working with a slightly different organ 
culture system, ovaries treated for seven days with estradiol and progesterone had no visible 
decline in oocyte number (Chen et al., 2007) and ovaries treated with genistein even had an 
increase in oocyte number (Jefferson et al., 2006), further confirming this assumption. Finally, 
the addition of DMSO to the media (solvent for estradiol) could have potential negative effects 
on ovarian health. Comparing DMSO vehicle controls to an organ culture control and an in vivo 
control would indicate any potential harmful effects of the DMSO. When looking at oocyte 
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number, percent single oocytes, and follicle development, there was no significant difference 
between DMSO vehicle controls and the organ culture control indicating that the DMSO did not 
have any detrimental effects. However, all three organ culture controls (two DMSO vehicle 
controls and organ culture control) were significantly different from the in vivo control in all 
three categories. This again indicates a potential problem with the organ culture system itself and 
its maintenance of ovarian health. Also, when looking at the effects on meiotic progression 
through analysis of MSY2 expression, the only group to be significantly different was the organ 
culture control (significant decrease in percent of oocytes strongly expressing MSY2 and 
significant increase in the number of oocytes not expressing MSY2 at all). 
 In summary, protein characterization of female germ cells through whole mount 
immunohistochemistry is a powerful tool for the field of reproduction and allows researchers to 
gain a complete picture of the ovary and its development. Researchers can visualize the 
expression of the protein of interest while also getting a clear picture of ovarian development 
through analysis of cyst breakdown, follicle formation, follicular development, and meiotic 
progression. Using this technique, characterization of two meiotic markers, MSY2 and SYCP3, 
was completed and can now be used to analyze the effects of other pathways involved with germ 
cell development, such as KIT signaling, or environmental factors, such as BPA and other 
endocrine disrupters. Here these two protein profiles were used to analyze the effects of 
exogenous hormone exposure and it was determined that estradiol and progesterone disrupt cyst 
breakdown and that progesterone significantly delays/disrupts meiotic progression of female 
germ cells. 
 In the future, work needs to be done investigating the organ culture system used in order 
to further optimize growing conditions and improve ovarian health while in the system. Once the 
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system is optimized, treatments of estradiol and progesterone should be repeated to confirm 
findings. Also, further investigation into the pathway that progesterone is acting on is required in 
order to better understand the effects of progesterone specifically on meiotic progression of 
female germ cells. Finally, with the use of the protein characterization profiles created here, 
further investigation into other pathways and environmental factors that may affect cyst 
breakdown and follicle formation can be completed through the use of the organ culture system 
and then analyzed with the profiles.  
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APPENDIX 1:  
Arrest at the diplotene stage of meiotic prophase I is delayed by progesterone but is not 
required for primordial follicle formation in mice 
Sudipta Dutta
1,2
, Deion Burks
1
, and Melissa Pepling
1*
 
 
 In order to assist in the research investigating diplotene arrest and the effects of steroid 
hormones on meiotic progression, I imaged and analyzed hematoxylin and eosin (H&E) stained 
ovarian sections and counted them for the number of oocytes found to be in the diplotene stage, 
the number oocytes found to be in pre-diplotene stages, and the percent of oocytes found to be in 
follicles for PND3, 4, and 5.  Images of H&E sections taken by myself were used for Figure 3 
(see attached article). Data collected for PND3, 4, and 5 were used in graphs for Figures 1 and 2 
(see attached article). 
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